John E Milad
@johnemilad.bsky.social
CEO at ERS Genomics | Reformed Venture Investor
“Rare” kidney diseases leave a deep and widespread impact. 160,000+ people in the UK are affected — driving 25% of dialysis demand and costing the NHS £263m a year.
As a @kidneyresearchuk.org Trustee, I’m calling for faster diagnosis and fairer access to care.
🔗 bit.ly/47Wdp5Z
#KidneyHealth
As a @kidneyresearchuk.org Trustee, I’m calling for faster diagnosis and fairer access to care.
🔗 bit.ly/47Wdp5Z
#KidneyHealth
Collectively common, rare kidney disease report - Kidney Research UK
A report about the impact of rare kidney diseases in the UK including diagnosis delays and waits for new treatments.
www.kidneyresearchuk.org
October 11, 2025 at 12:18 AM
“Rare” kidney diseases leave a deep and widespread impact. 160,000+ people in the UK are affected — driving 25% of dialysis demand and costing the NHS £263m a year.
As a @kidneyresearchuk.org Trustee, I’m calling for faster diagnosis and fairer access to care.
🔗 bit.ly/47Wdp5Z
#KidneyHealth
As a @kidneyresearchuk.org Trustee, I’m calling for faster diagnosis and fairer access to care.
🔗 bit.ly/47Wdp5Z
#KidneyHealth